Ancora Advisors, LLC Biogen Inc. Transaction History

Ancora Advisors, LLC

$3.73 Billion
Q2 2024

A detailed history of Ancora Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 45 shares of BIIB stock, worth $7,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 80 43.75%

Holding current value

$7,820

Previous $17,000 41.18%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $6,668 - $8,285	-35 Reduced 43.75%	45 $10,000
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $34,135 - $43,101	-161 Reduced 66.8%	80 $17,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $6,414 - $7,308	25 Added 11.57%	241 $67,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $6,311 - $7,668	-25 Reduced 10.37%	216 $60,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $29,203 - $40,269	-150 Reduced 38.36%	241 $64,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $185,437 - $233,641	-957 Reduced 70.99%	391 $82,000
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $163,348 - $205,810	843 Added 166.93%	1,348 $377,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $194,362 - $249,784	-868 Reduced 63.22%	505 $121,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $7,074 - $9,226	25 Added 1.85%	1,373 $389,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $6,073 - $7,115	-25 Reduced 1.82%	1,348 $377,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $10,631 - $16,003	-45 Reduced 3.17%	1,373 $336,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $132,385 - $152,855	-500 Reduced 26.07%	1,418 $402,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $756,063 - $1 Million	-2,923 Reduced 60.38%	1,918 $513,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $320,738 - $406,860	-1,193 Reduced 19.77%	4,841 $1.53 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $8,362 - $11,554	38 Added 0.63%	6,034 $1.79 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $239,184 - $268,268	1,100 Added 22.47%	5,996 $1.4 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $126,091 - $138,989	-575 Reduced 10.51%	4,896 $1.15 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $5,417 - $8,474	-25 Reduced 0.45%	5,471 $1.29 Million
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $34,812 - $44,093	125 Added 2.33%	5,496 $1.65 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.58 Million - $2.06 Million	5,371 New	5,371 $1.9 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $1.71 Million - $2.04 Million	-6,650 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $107,953 - $152,682	415 Added 6.66%	6,650 $1.82 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $99,675 - $111,643	324 Added 5.48%	6,235 $1.99 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $1.66 Million - $1.95 Million	5,911	5,911 $1.85 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Biogen Inc. Transaction History